We note that the other dienone compounds (Supplementary Figure S2) did not show the differences in the IC50 between p53 mutant and wild-type tumor cell lines in the NCI60 cell line panel, raising the possibility that reactivation of p53 is not a general property of this class of compounds. The gene discussed is TP53; the disease is neoplasm.